LDK 150MG NVR Pill - blue & white capsule/oblong
Generic Name: ceritinib
Pill with imprint LDK 150MG NVR is Blue & White, Capsule/Oblong and has been identified as Zykadia 150 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Zykadia is used in the treatment of Non-Small Cell Lung Cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Zykadia 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LDK 150MG NVR
Zykadia
- Generic Name
- ceritinib
- Imprint
- LDK 150MG NVR
- Strength
- 150 mg
- Color
- Blue & White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0640 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
hydroxypropyl cellulose,
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
gelatin,
titanium dioxide,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
More about Zykadia (ceritinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
